(Registrieren)

EANS-News: Alpha Beta Netherlands Holding N.V.: Management and Supervisory Board of Deutsche Börse issue joint supplemental statement on exchange offer of Alpha Beta Netherlands Holding N.V.

Geschrieben am 08-07-2011

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Company Information/Mergers - Acquisitions - Takeovers

Amsterdam (euro adhoc) - Amsterdam, July 8, 2011 - The management
board and the supervisory board of Deutsche Börse AG ("Deutsche
Börse") have issued a joint supplemental statement pursuant to
Section 27 German Takeover Act (the "Supplemental Statement") on the
amendment to the voluntary public takeover offer (Exchange Offer)
published on 27 June 2011 made by Alpha Beta Netherlands Holding
N.V., Amsterdam/Netherlands, to the shareholders of Deutsche Börse.
The Supplemental Statement is available on the internet at both the
homepage of Deutsche Börse at
http://www.deutsche-boerse.com/supplementalstatement and at the
homepage of Alpha Beta Netherlands Holding N.V. at
http://www.global-exchange-operator.com.

Alpha Beta Netherlands Holding N.V.

Disclaimer
Safe Harbour Statement

In connection with the proposed business combination transaction
between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands
Holding N.V. ("Holding"), a newly formed holding company, has filed,
and the SEC has declared effective on May 3, 2011, a Registration
Statement on Form F-4 with the U.S. Securities and Exchange
Commission ("SEC") that includes (1) a proxy statement of NYSE
Euronext that will also constitute a prospectus for Holding and (2)
an offering prospectus of Holding to be used in connection with
Holding´s offer to acquire Deutsche Boerse AG shares held by U.S.
holders. Holding has also filed an offer document with the German
Federal Financial Supervisory Authority (Bundesanstalt fuer
Finanzdienstleistungsaufsicht) (the "BaFin"), which was approved by
the BaFin for publication pursuant to the German Takeover Act
(Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4,
2011.

Investors and security holders are urged to read the definitive proxy
statement/prospectus, the offering prospectus, the offer document, as
amended, and published additional accompanying information in
connection with the exchange offer regarding the proposed business
combination transaction because they contain important information.
You may obtain a free copy of the definitive proxy
statement/prospectus, the offering prospectus and other related
documents filed by NYSE Euronext and Holding with the SEC on the
SEC´s website at www.sec.gov. The definitive proxy
statement/prospectus and other documents relating thereto may also be
obtained for free by accessing NYSE Euronext´s website at
www.nyse.com. The offer document, as amended, and published
additional accompanying information in connection with the exchange
offer are available at Holding´s website at
www.global-exchange-operator.com. Holders of Deutsche Börse shares
who have accepted the exchange offer have certain withdrawal rights
which are set forth in the offer document.

This document is neither an offer to purchase nor a solicitation of
an offer to sell shares of Holding, Deutsche Boerse AG or NYSE
Euronext. The final terms and further provisions regarding the public
offer are disclosed in the offer document that has been approved by
the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a
prospectus meeting the requirements of Section 10 of the U.S.
Securities Act of 1933, as amended, and applicable European
regulations. The exchange offer and the exchange offer document as
well amended, shall not constitute an issuance, publication or public
advertising of an offer pursuant to laws and regulations of
jurisdictions other than those of Germany, United Kingdom of Great
Britain and Northern Ireland and the United States of America. The
relevant final terms of the proposed business combination transaction
will be disclosed in the information documents reviewed by the
competent European market authorities.

Subject to certain exceptions, in particular with respect to
qualified institutional investors (tekikaku kikan toshika) as defined
in Article 2 para. 3 (i) of the Financial Instruments and Exchange
Act of Japan (Law No. 25 of 1948, as amended), the exchange offer
will not be made directly or indirectly in or into Japan, or by use
of the mails or by any means or instrumentality (including without
limitation, facsimile transmission, telephone and the internet) of
interstate or foreign commerce or any facility of a national
securities exchange of Japan. Accordingly, copies of this
announcement or any accompanying documents may not be, directly or
indirectly, mailed or otherwise distributed, forwarded or transmitted
in, into or from Japan.

The shares of Holding have not been, and will not be, registered
under the applicable securities laws of Japan. Accordingly, subject
to certain exceptions, in particular with respect to qualified
institutional investors (tekikaku kikan toshika) as defined in
Article 2 para. 3 (i) of the Financial Instruments and Exchange Act
of Japan (Law No. 25 of 1948, as amended), the shares of Holding may
not be offered or sold within Japan, or to or for the account or
benefit of any person in Japan.

Participants in the Solicitation

NYSE Euronext, Deutsche Boerse AG, Holding and their respective
directors and executive officers and other members of management and
employees may be deemed to be participants in the solicitation of
proxies from NYSE Euronext stockholders in respect of the proposed
business combination transaction. Additional information regarding
the interests of such potential participants will be included in the
definitive proxy statement/prospectus and the other relevant
documents filed with the SEC.

Forward-Looking Statements

This document includes forward-looking statements about NYSE
Euronext, Deutsche Boerse AG, Holding, the enlarged group and other
persons, which may include statements about the proposed business
combination, the likelihood that such transaction could be
consummated, the effects of any transaction on the businesses of NYSE
Euronext or Deutsche Boerse AG, and other statements that are not
historical facts. By their nature, forward-looking statements involve
risks and uncertainties because they relate to events and depend on
circumstances that may or may not occur in the future.
Forward-looking statements are not guarantees of future performance
and actual results of operations, financial condition and liquidity,
and the development of the industries in which NYSE Euronext and
Deutsche Boerse AG operate may differ materially from those made in
or suggested by the forward-looking statements contained in this
document. Any forward-looking statements speak only as at the date of
this document. Except as required by applicable law, none of NYSE
Euronext, Deutsche Boerse AG or Holding undertakes any obligation to
update or revise publicly any forward-looking statement, whether as a
result of new information, future events or otherwise.

Alpha Beta Netherlands Holding N.V.

Further inquiry note:
Alpha Beta Netherlands Holding N.V.

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Alpha Beta Netherlands Holding N.V.
Beursplein 5
NL-1012 JW Amsterdam
WWW: http://www.global-exchange-operator.com
sector: Holding companies
ISIN: NL0009766997
indexes:
stockmarkets:
language: English


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

341764

weitere Artikel:
  • EANS-News: Alpha Beta Netherlands Holding N.V.: Vorstand und Aufsichtsrat der Deutsche Börse geben gemeinsame ergänzende Stellungnahme zum Übernahmeangebot der Alpha Beta Netherlands Holding N.V. ab -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- Unternehmen/Fusion/Übernahme/Beteiligung Amsterdam (euro adhoc) - Amsterdam, 8. Juli 2011 - Der Vorstand und der Aufsichtsrat der Deutsche Börse AG ("Deutsche Börse") haben eine gemeinsame ergänzende Stellungnahme gemäß § 27 Wertpapiererwerbs- und Übernahmegesetz mehr...

  • QIAGEN schließt Vereinbarung über den Erwerb von 61% an Ipsogen ab, plant vollständige Übernahme des führenden Anbieters molekulardiagnostischer Tests für die Onkologie Venlo, Niederlande (ots) - - Verbindliche Vereinbarung basiert auf QIAGENs Angebot vom Juni 2011 für den Erwerb von Anteilen an Ipsogen S.A. und ein anschließendes öffentliches Angebot zur vollständigen Übernahme des Unternehmens - Ipsogen verfügt über wettbewerbsfähiges Testportfolio für Diagnostik und Monitoring von Leukämiepatienten auf Basis von 15 Biomarkern - Zahlreiche Ipsogen-Tests verfügen über großes Potenzial für den Einsatz als therapiebegleitende Diagnostika zur Personalisierung mehr...

  • QIAGEN aktualisiert Angebot zur Übernahme von Celletis Venlo, die Niederlande und Melbourne, Australien (ots) - - QIAGEN erhöht Angebot an die Aktionäre von Cellestis Limited (CST: AU) zu Bedingungen der Übernahmevereinbarung - Cellestis-Vorstand(1) unterstützt einstimmig aktualisiertes Übernahmeangebot, das einer Erhöhung um 7% auf A$3,80 je Aktie von ursprünglich A$3,55 entspricht - Akquisition würde QIAGEN exklusiven Zugang zur QuantiFERON®-Technologie für hochsensitive und frühe Krankheitsdiagnostik eröffnen, die auf anderer Basis nicht mehr...

  • Lilly CEO empfiehlt Einbeziehung von Biopharmazeutika in transatlantische Handels- und Wirtschaftsgespräche Berlin (ots/PRNewswire) - Grössere Kooperation in der Biopharmazie würde zu technologischem Fortschritt, Beschäftigungswachstum und gesellschaftlichem Nutzen führen John C. Lechleiter, Ph.D., Chairman, President und Chief Executive Officer von Eli Lilly and Company , forderte heute, Biopharmazeutika in die transatlantischen Handels- und Wirtschaftsgespräche einzubeziehen. Lechleiter nahm am American Council teil, dass die Konferenz in Deutschland über "Die Transatlantische mehr...

  • EANS-News: Wüstenrot & Württembergische beauftragt USU AG für Projekt Vorsorge-Beratung -------------------------------------------------------------------------------- Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. -------------------------------------------------------------------------------- Lizenzverträge/Großauftrag Möglingen (euro adhoc) - Die USU AG hat den von der Wüstenrot & Württembergische Informatik GmbH ausgeschriebenen Projektwettbewerb zur Realisierung der Vorsorge-Beratungssoftware für den Vorsorge-Spezialisten W&W AG gewonnen. Der Auftrag mehr...

Mehr zu dem Thema Finanzen

Der meistgelesene Artikel zu dem Thema:

Century Casinos wurde in Russell 2000 Index aufgenommen

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht